It's been another week of turmoil in British Brexit politics, but what is the view from the rest of Europe? Is the EU any better organised than the British government and what do they think is actually going to happen? Jonty Bloom takes a Europe-wide view of Brexit and the preparations already underway. He is joined by: Vicky Pryce, chief economic adviser at the Centre for Economics and Business Research; Melle Garshagen, UK and Ireland correspondent for the Dutch newspaper NRC Handelsblad; and Ilja Nothnagel of the German Chambers of Commerce and Industry.
(Picture: Englishman standing on the beach, overlooking the sea; Credit: Getty Images)
China's 40 Year Economic Miracle
China is marking 40 years since the economic reforms of Deng Xiaoping kick-started the changes that turned the Communist country into a super-power. But are some of those reforms now coming to an end? China's current leader, President Xi Jinping, is concentrating more power under his control and has to deal with bloated state-owned companies. Anu Anand is joined by guests who remember how the reforms transformed society, but also warn of the dangers China's economy still faces today.
Contributors: Charles Parton, former British diplomat in Beijing. Associate Fellow at RUSI
Andy Xie, independent economist based in Shanghai
Yu Jie, Research Fellow, Chatham House
Michael Pettis, finance professor at Peking University
Producer: Audrey Tinline
(Picture:Tourists pose for their friend's camera in front of the Deng Xiaoping billboard in Shenzhen, China. (Credit; Corbis via Getty Images)
The EU: Saviour or Oppressor?
Populist and nationalist political parties are on the rise in some parts of Europe, as the battle gets underway for European elections next year. Rob Young hears from guests from Italy, Poland and Brussels about their differing visions for the European Union and why it needs to adapt, or some fear, die.
Contributors: Maria Demertzis, Deputy Director at Bruegel
Przemysław Kowalski, President of CASE, the Center for Social and Economic Research, Poland
Lorenzo Marsili, Writer, political activist and co-founder of European Alternatives
(Picture:The Eu and UK flags on the front page of document reading: 'Article 50 - European Council' before the special meeting of the European Council to endorse the draft Brexit withdrawal agreement. November 25, 2018 in Brussels. (Credit: EMMANUEL DUNAND / AFP/ Getty Images)
How do you juggle the demands of a job and a family? Is there a stress-free and guilt-free way of giving adequate attention to your children and your career?
We discuss the daily challenges facing millions of parents all over the world, including the often frantic morning rush, the career opportunities that pass you by, and the difficulty of maintaining a social life.
And in this, the last episode of the series, we have three presenters instead of one - Susannah Streeter and Nkem Ifejika join fellow working parent Manuela Saragosa to share some tips. They're joined by Clare Streets, from Birmingham in the UK, who has recently rejoined the world of work after seven years spent raising a family.
(Picture: A woman multi-tasking. Credit: Getty Images)
The Price of Pills
Drug firms are coming under fire from the US, Europe and China over the cost of some of their products. But is it simply the price we have to pay if we want Big Pharma to keep producing life-saving medicines?
President Trump has vowed to drive down drug prices "substantially" - we hear why a lack of haggling means the latest patented pills typically cost more in the US than almost anywhere else in the world.
We hear from Big Pharma itself - an industry figure tells us high prices reflect the years of research and development that go into new drugs and that, in time, competition does make them cheaper.
Plus, does size matter when brokering better deals with the pharmaceutical firms, and in lower income countries what are the other factors pushing up prices?
Contributors: Patricia Danzon, professor of health care management at The Wharton School, University of Pennsylvania; Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations; and Kalipso Chalkidou, director of global health policy at the Center for Global Development.
(Picture: Pills on a US dollar bill. Credit: Getty Images)